Skip to main content
. 2013 Dec 23;8(12):e83607. doi: 10.1371/journal.pone.0083607

Table 5. Cases with mutations detected by Next Generation Sequencing but not by Sanger sequencing.

# Case Total tumor cell number Tumor cell % EGFR status (Ex18-21) according to Sanger sequencing EGFR status (Ex18-21) according to NGS Ex % of mutated   reads Predicted role for TKI treatment Clinical relevance of mutations detected by NGS but not by Sanger Specimen Type Diagnosis
67 1,392 5 WT del E746-A751 19 2 RESPONSIVE YES C NSCLC
80 858 5 WT L858R 21 6 RESPONSIVE YES B ACA Bone Met
63 3,240 10 WT del K745-A750 19 2 RESPONSIVE YES C ACA
76 952 15 WT del E746-A750 19 2 RESPONSIVE YES C ACA
39 3,720 25 WT D807G 20 16 Mut. not described NO C NSCLC
57 4,672 35 WT G721W 20 4 Mut. not described C ACA LN Met
R831H 21 3 RESISTANCE YES
25 NA <40 WT S752F 20 5.2 Mut. not described NO C ACA
T785I 21 10 UNDEFINED
30 NA >40 F795S 20 16 UNDEFINED NO C NSCLC
L858R L858R 21 20 RESPONSIVE
2 228,150 46 del E746-A750 del E746-A750 19 49 RESPONSIVE NO C ACA
P772S 20 1 RESPONSIVE
68 1,390 50 P691T 18 2.4 Mut. not described B ACA
T790M T790M 20 26 RESISTANCE NO
L858R L858R 21 26 RESPONSIVE
79 18,000 50 WT del L747-A750 insP 19 4 RESPONSIVE YES C NSCLC LN Met
62 42,504 60 K708N 18 2.5 Mut. not described NO B ACA LN Met
G719A G719A 18 38 RESPONSIVE
59 20,784 80 WT V845M 21 1.5 UNDEFINED NO B ACA Trachea Met
66 11,410 80 WT del L747-S752 19 1.7 RESPONSIVE YES B ACA

Ex, Exon; B, biopsy sample; C, cytology sample; LN, lymph node; Met, metastasis; NSLC, non-small cell Lung carcinoma; ACA, adenocarcinoma; NA, not available; WT, wild type; del, deletion; ins, insertion; mut., mutation.